Celyad Oncology ADR (CYAD) inventory is decrease via -49.40% during the last twelve months, and the common ranking from Wall Side road analysts is a Purchase. InvestorsObserver’s proprietary rating gadget, provides CYAD inventory a ranking of 0 out of a imaginable 100.
That rank is basically influenced via a temporary technical ranking of 0. CYAD’s rank additionally features a long-term technical ranking of 0.
What is Going down with CYAD Inventory Lately
Celyad Oncology ADR (CYAD) inventory is buying and selling at $2.10 as of 12:34 PM on Tuesday, Aug 2, a decline of -$0.35, or -14.29% from the former final value of $2.45. The inventory has traded between $1.96 and $2.36 up to now nowadays. Quantity nowadays is 322,255 in comparison to reasonable quantity of 259,090.
Keep In The Know
Subscribe to our day by day morning replace e-newsletter and not fail to spot the need-to-know marketplace information, actions, and extra.